The Microbiome and Risk for Obesity and Diabetes

  title={The Microbiome and Risk for Obesity and Diabetes},
  author={Anthony L. Komaroff},
  • A. Komaroff
  • Published 24 January 2017
  • Biology, Medicine
  • JAMA
Obesity and type 2 diabetes mellitus are influenced both by genes and lifestyle. That is not news. However, the genes in the human microbiome also may play an important role, and that is news. It has been known for decades that gut bacteria synthesize essential vitamins and amino acids and help degrade toxins. During the past decade, it has become clear that the influence of the microbiome on health may be even more profound. Beginning at the moment of birth, each human increasingly coexists… 

The Microbiome and Risk for Atherosclerosis

Considerable evidence indicates that the human gut microbiome may affect the development and progression of Atherosclerosis, both by influencing risk factors for atherosclerosis and by direct effects on the initiation and progressionof atherosclerotic plaques.

The journey of gut microbiome – An introduction and its influence on metabolic disorders

A lucid understanding of the complex host-microbiome inter-relationships will open avenues to novel therapeutics for the diagnosis, prevention and treatment of the metabolic diseases.

Research progress on the role of intestinal flora in obesity and diabetes intervention

Intestinal microflora is also known as the second set of genomes, which is closely related to human health, and as a biomarker associated with disease, microbial macro genome research has high hopes for precision medicine.

Microbiota and metabolic diseases

The microbiota is a complex ecosystem of microorganisms consisting of bacteria, viruses, protozoa, and fungi, living in different districts of the human body, such as the gastro-enteric tube, skin, mouth, respiratory system, and the vagina, which plays a major role in many metabolic functions.

Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship.

Recent research provides evidence that the gut microbiome plays a substantial role in estrogen regulation, and Gut microbiota diversity appears to be an essential component of overall health, including breast health.

The Impact of Intestinal Microorganisms and Their Metabolites on Type 1 Diabetes Mellitus

Support is provided for the notion that intestinal microbiota contributes to the regulation of T1DM occurrence and development and may become a potential target for novel therapeutics.

Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ

The various mechanisms through which the gut microbiota influences adipose tissue dysfunction and metabolic processes that subsequently cause cardiovascular diseases are summarized, highlighting the complex interactions between gut microbes, their metabolites, and the metabolic activity of the host.

Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals

The gut microbiota signature of 60 Pakistani adults was studied and it was revealed that bacteria from Firmicutes were predominant along with those from Clostridia and Negativicutes, whereas bacteria from Verrucomicrobia, Bacteroidetes, Proteobacteria, and Elusimicrobia were less abundant among the obese T2DM patients.

Gut microbiome and microbial metabolites: a new system affecting metabolic disorders

  • M. Federici
  • Medicine, Biology
    Journal of Endocrinological Investigation
  • 2019
The combination of metagenomics and metabolomics-based signature might be applied in the future to improve the risk prediction in healthy subjects to argue whether the current achievements may be translated into clinical practice.



The human gut microbiome and body metabolism: implications for obesity and diabetes.

Advances in the Human Microbiome Project and human metagenomics research will lead the way toward a greater understanding of the importance and role of the gut microbiome in metabolic disorders such as obesity, metabolic syndrome, and diabetes.

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

A unified signature of gut microbiome shifts in T2D with a depletion of butyrate-producing taxa is reported, highlighting the need to disentangle gut microbiota signatures of specific human diseases from those of medication.

An obesity-associated gut microbiome with increased capacity for energy harvest

It is demonstrated through metagenomic and biochemical analyses that changes in the relative abundance of the Bacteroidetes and Firmicutes affect the metabolic potential of the mouse gut microbiota and indicates that the obese microbiome has an increased capacity to harvest energy from the diet.

The gut microbiota as an environmental factor that regulates fat storage.

It is found that conventionalization of adult germ-free (GF) C57BL/6 mice with a normal microbiota harvested from the distal intestine of conventionally raised animals produces a 60% increase in body fat content and insulin resistance within 14 days despite reduced food intake.

Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity

Findings provide the first empirical support for the claim that changes in the gut microbiota contribute to reduced host weight and adiposity after RYGB surgery, and suggest new approaches to the treatment of obesity and related metabolic diseases that harness the ability of the Gut microbiota to influence host metabolic physiology.

Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome

It is shown that increased production of acetate by an altered gut microbiota leads to activation of the parasympathetic nervous system which in turn promotes increased glucose-stimulated insulin secretion (GSIS), increased ghrelin secretion, hyperphagia, obesity and its related sequelae.

Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

The results reveal that transmissible and modifiable interactions between diet and microbiota influence host biology and that adiposity is transmissible from human to mouse and that it was associated with changes in serum levels of branched-chain amino acids.

Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study.

Early probiotic supplementation may reduce the risk of islet autoimmunity in children at the highest genetic risk of T1DM, according to a time-to-event analysis study.

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Six weeks after infusion of microbiota from lean donors, insulin sensitivity of recipients increased along with levels of butyrate-producing intestinal microbiota, and intestinal microbiota might be developed as therapeutic agents to increase insulin sensitivity in humans.